Analytical Data
-
基因名
VCX3A
- Application
-
别名
VCX3A; VCX3; VCX8R; VCXAVariable charge X-linked Protein 3; Variable charge Protein on X with eight repeats; VCX-8r; Variably charged Protein X-A; VCX-A
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NNX9
-
表达区间
1-186 aa
-
氨基酸序列
MSPKPRASGP PAKATEAGKR KSSSQPSPSD PKKKTTKVAK KGKAVRRGRR GKKGAATKMA AVTAPEAESG PAAPGPSDQP SQELPQHELP PEEPVSEGTQ HDPLSQESEL EEPLSQESEV EEPLSQESQV EEPLSQESEV EEPLSQESQV EEPLSQESEV EEPLSQESQV EEPLSQESEM EELPSV
-
分子量
20 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VCX3A, a member of the vacuolar protein sorting protein family, has garnered significant interest in recent years due to its potential roles in various cellular processes and its implications in disease mechanisms. Originally identified in studies related to cellular stress responses, VCX3A is speculated to function in ion transport, particularly in maintaining cellular calcium homeostasis, which is crucial for numerous physiological functions. Research has indicated that disruptions in VCX3A expression or function may be linked to neurological disorders and other conditions, highlighting the need for a deeper understanding of its structure and function. Consequently, the recombinant expression of VCX3A has become an essential area of investigation, enabling the characterization of its biochemical properties and the elucidation of its role in cellular physiology. By generating recombinant VCX3A proteins, researchers aim to explore their potential interactions with other cellular components, elucidate their structural features, and identify their functional mechanisms, thereby contributing to the development of targeted therapeutic strategies and advancing our understanding of diseases associated with VCX3A dysregulation. This research plays a crucial role in bridging the gap between basic science and clinical applications, paving the way for future studies in molecular biology and pharmacology.
